Follow
Byron Andrews
Byron Andrews
Storm Therapeutics
Verified email at stormtherapeutics.com - Homepage
Title
Cited by
Cited by
Year
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
E Yankova, W Blackaby, M Albertella, J Rak, E De Braekeleer, ...
Nature 593 (7860), 597-601, 2021
6092021
METTL1 promotes let-7 MicroRNA processing via m7G methylation
L Pandolfini, I Barbieri, AJ Bannister, A Hendrick, B Andrews, N Webster, ...
Molecular Cell 74 (6), 1278-1290. e9, 2019
3362019
Assembly factors for the membrane arm of human complex I
B Andrews, J Carroll, S Ding, IM Fearnley, JE Walker
Proceedings of the National Academy of Sciences 110 (47), 18934-18939, 2013
1582013
A flat BAR protein promotes actin polymerization at the base of clathrin-coated pits
L Almeida-Souza, RAW Frank, J García-Nafría, A Colussi, ...
Cell 174 (2), 325-337. e14, 2018
1092018
METTL15 introduces N4-methylcytidine into human mitochondrial 12S rRNA and is required for mitoribosome biogenesis
LV Haute, AG Hendrick, AR D’Souza, CA Powell, P Rebelo-Guiomar, ...
Nucleic Acids Research 47 (19), 10267-10281, 2019
792019
A computational platform for high-throughput analysis of RNA sequences and modifications by mass spectrometry
S Wein, B Andrews, T Sachsenberg, H Santos-Rosa, O Kohlbacher, ...
Nature communications 11 (1), 926, 2020
672020
Further evidence supporting N7-methylation of guanosine (m7G) in human microRNAs
T Kouzarides, L Pandolfini, I Barbieri, AJ Bannister, B Andrews
Molecular Cell 79 (2), 201-202, 2020
172020
Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity
AA Guirguis, Y Ofir-Rosenfeld, K Knezevic, W Blackaby, D Hardick, ...
Cancer Discovery 13 (10), 2228-2247, 2023
162023
A late-stage assembly checkpoint of the human mitochondrial ribosome large subunit
P Rebelo-Guiomar, S Pellegrino, KC Dent, A Sas-Chen, L Miller-Fleming, ...
Nature communications 13 (1), 929, 2022
152022
Towards SINEUP-based therapeutics: Design of an in vitro synthesized SINEUP RNA
P Valentini, B Pierattini, E Zacco, D Mangoni, S Espinoza, NA Webster, ...
Molecular Therapy-Nucleic Acids 27, 1092-1102, 2022
92022
Multidimensional dynamics of the proteome in the neurodegenerative and aging mammalian brain
B Andrews, AE Murphy, M Stofella, S Maslen, L Almeida-Souza, ...
Molecular & Cellular Proteomics 21 (2), 2022
72022
Remodeling of the m6A RNA landscape in the conversion of acute lymphoblastic leukemia cells to macrophages
A Bueno-Costa, D Piñeyro, CA García-Prieto, V Ortiz-Barahona, ...
Leukemia 36 (8), 2121-2124, 2022
62022
Inhibition of n6-methyladenosine (m6a) modification as a novel treatment strategy for alk-positive anaplastic large cell lymphoma (ALCL)
L Mun, V Miano, N Webster, B Andrews, N Han, A Burke, I Barberi, ...
Leukemia Research 121, S29, 2022
12022
Abstract LB171: First-in-class inhibitors of the tRNA methyltransferase METTL1 for the treatment of cancer
A Sapetschnig, B Thomas, E Yankova, H Fischl, A Azevedo, S Bucknell, ...
Cancer Research 84 (7_Supplement), LB171-LB171, 2024
2024
105P Targeting the tRNA methyltransferase METTL1 with small molecule inhibitors in cancer
A Sapetschnig, B Thomas, E Yankova, H Fischl, A Azevedo, S Bucknell, ...
ESMO Open 9, 2024
2024
RNA-Modifying Enzymes and Their Inhibitors
WP Blackaby, B Andrews, B Thomas, D Hardick, EA Miska
2020 Medicinal Chemistry Reviews 55, 451-468, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–16